CID 53481220

Ganglioside gq1c (d18:0/25:0)

Structural Information

Molecular Formula
C114H199N5O55
SMILES
CCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O[C@@]5(C[C@@H]([C@H](C(O5)[C@@H]([C@@H](CO)O)O)NC(=O)C)O)C(=O)O)O)CC(=O)C)O[C@@]6(C[C@@H]([C@H](C(O6)[C@@H]([C@@H](CO)O[C@@]7(C[C@@H]([C@H](C(O7)[C@@H]([C@@H](CO)O[C@@]8(C[C@@H]([C@H](C(O8)[C@@H]([C@@H](CO)O)O)NC(=O)C)O)C(=O)O)O)NC(=O)C)O)C(=O)O)O)NC(=O)C)O)C(=O)O)O)O)O)[C@@H](CCCCCCCCCCCCCCC)O
InChI
InChI=1S/C114H199N5O55/c1-8-10-12-14-16-18-20-22-23-24-25-26-27-28-29-30-32-34-36-38-40-42-44-79(140)119-65(66(133)43-41-39-37-35-33-31-21-19-17-15-13-11-9-2)58-159-104-91(148)90(147)95(77(56-126)162-104)165-106-93(150)102(96(78(57-127)163-106)166-103-64(45-59(3)128)94(86(143)73(52-122)160-103)164-105-92(149)101(87(144)74(53-123)161-105)173-113(109(155)156)48-69(136)81(116-61(5)130)98(170-113)85(142)72(139)51-121)174-114(110(157)158)49-70(137)83(118-63(7)132)100(172-114)89(146)76(55-125)168-112(108(153)154)47-68(135)82(117-62(6)131)99(171-112)88(145)75(54-124)167-111(107(151)152)46-67(134)80(115-60(4)129)97(169-111)84(141)71(138)50-120/h64-78,80-106,120-127,133-139,141-150H,8-58H2,1-7H3,(H,115,129)(H,116,130)(H,117,131)(H,118,132)(H,119,140)(H,151,152)(H,153,154)(H,155,156)(H,157,158)/t64-,65+,66-,67+,68+,69+,70+,71-,72-,73-,74-,75-,76-,77-,78-,80-,81-,82-,83-,84-,85-,86+,87+,88-,89-,90-,91-,92-,93-,94-,95-,96+,97?,98?,99?,100?,101+,102-,103+,104-,105+,106+,111-,112-,113+,114+/m1/s1
InChIKey
LVJYFZMFHUACMV-ZKFMYSRJSA-N
Compound name
(2S,4S,5R)-5-acetamido-2-[(2R,3R,4S,5S,6R)-2-[(2S,3R,4R,5R,6R)-2-[(2R,3S,4R,5R,6S)-4-[(2S,4S,5R)-5-acetamido-6-[(1S,2R)-2-[(2S,4S,5R)-5-acetamido-6-[(1S,2R)-2-[(2S,4S,5R)-5-acetamido-2-carboxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxan-2-yl]oxy-1,3-dihydroxypropyl]-2-carboxy-4-hydroxyoxan-2-yl]oxy-1,3-dihydroxypropyl]-2-carboxy-4-hydroxyoxan-2-yl]oxy-6-[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2S,3R)-3-hydroxy-2-(pentacosanoylamino)octadecoxy]oxan-3-yl]oxy-5-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)-3-(2-oxopropyl)oxan-4-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

2518.293 Da
Monoisotopic Mass

1.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2519.3003 474.9
[M+Na]+ 2541.2822 478.9
[M+NH4]+ 2536.3268 480.2
[M+K]+ 2557.2562 461.4
[M-H]- 2517.2857 479.3
[M+Na-2H]- 2539.2677 494.2
[M]+ 2518.2925 481.7
[M]- 2518.2935 481.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.